Concepedia

Yanqun Shu

YS

Statistics

Publications

8

Citations

349

H-Index

8

Active since

2003

Affiliations

University of Minnesota(Current)

Masonic Cancer Center

University of Minnesota Medical Center

Twin Cities Orthopedics

NHS Blood and Transplant

Yanqun Shu is an author at University of Minnesota specializing in medicine, pharmacology, and immunology.

Top concepts

Publications per year

2003–2013

8

Publications

8

A Bispecific Recombinant Immunotoxin, DT2219, Targeting Human CD19 and CD22 Receptors in a Mouse Xenograft Model of B-Cell Leukemia/Lymphoma

Daniel A. Vallera, D.A. Todhunter, David W. Kuroki et al. · Clinical Cancer Research · 2005 · 99 citations

Design of a superior cytokine antagonist for topical ophthalmic use

Jinzhao Hou, Sharon A. Townson, Joseph Kovalchin et al. · Proceedings of the National Academy of Sciences · 2013 · 59 citations · Full text

, , +27

Increasing Anticarcinoma Activity of an Anti-erbB2 Recombinant Immunotoxin by the Addition of an Anti-EpCAM sFv

B.J. Stish, Hua Chen, Yanqun Shu et al. · Clinical Cancer Research · 2007 · 44 citations · Full text

Bioengineering a Unique Deimmunized Bispecific Targeted Toxin That Simultaneously Recognizes Human CD22 and CD19 Receptors in a Mouse Model of B-Cell Metastases

Daniel A. Vallera, Seunguk Oh, Hua Chen et al. · Molecular Cancer Therapeutics · 2010 · 35 citations · Full text

, , +17

Molecular modification of a recombinant, bivalent anti-human CD3 immunotoxin (Bic3) results in reduced in vivo toxicity in mice

Daniel A. Vallera, D.A. Todhunter, David W. Kuroki et al. · Leukemia Research · 2004 · 34 citations

, , +10

1–5 of 8